Manufacturer record
Biogenetic Drugs Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Biogenetic Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 501024-BG197, Vitamin C Tablets IP 500mg (exp Sep 2026). FDAL, Mumbai (state lab) found it not of standard quality: Almost all the tablets received for analysis shows brown-colored spots all over the surface of the tablets, when observed in normal daylight. Listed in the September 2026 alert.
Records by type
14 records linked to Biogenetic Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Vitamin C Tablets IP 500mg | Batch 501024-BG197Mfg Oct 2024 · Exp Sep 2026 | Almost all the tablets received for analysis shows brown-colored spots all over the surface of the tablets, when observed in normal daylight conditions with unaided eyes.Description | FDAL, MumbaiState lab | Sep 2026 |
| Iron & Folic Acid Syrup IP | Batch 740525-BKN20Mfg May 2025 · Exp Apr 2027 | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Iron & Folic Acid Syrup IP | Batch 880525-BKN20Mfg May 2025 · Exp Apr 2027 | Test for pH and Assay for Elemental IronAssay | DTL, Bengaluru, KarnatakaState lab | Jan 2026 |
| Iron & Folic Acid Syrup IP | Batch 1340625-BKN20Mfg Jun 2025 · Exp May 2027 | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Jan 2026 |
| Albendazole Tablets IP 400 mg | Batch 010625-BTP3Mfg Jun 2025 · Exp May 2027 | DissolutionDissolution | State Drugs Testing Laboratory, Govt. of Tripura, AgartalaCDSCO lab | Aug 2025 |
| Ibuprofen TabletsIP 400 mg | Batch 060124-BKN13Mfg Jan 2024 · Exp Dec 2025 | DescriptionDescription | KarnatakaState lab | Jul 2025 |
| Ibuprofen TabletsIP 200 mg | Batch 020125-BCG01Mfg Jan 2025 · Exp Dec 2026 | DissolutionDissolution | Drug Control Department ChhattisgarhState lab | Jul 2025 |
| Ibuprofen Tablets IP 400mg | Batch 290524-BKN13Mfg May 2024 · Exp Apr 2026 | Test for DissolutionDissolution | KarnatakaState lab | Jul 2025 |
| Ibuprofen Tablets IP 400 mg | Batch 270524-BKN13,Mfg May 2024 · Exp Apr 2026 | Dissolution of IbuprofenDissolution | State Lab KarnatakaState lab | Jun 2025 |
| Ibuprofen Tablets IP 400 mg | Batch 310524-BKN13Mfg May 2024 · Exp Apr 2026 | Dissolution of IbuprofenDissolution | State Lab KarnatakaState lab | Jun 2025 |
| Aluminium Hydroxide, Magnesium Trisilicate and Activated Polydimethylsiloxan e Suspension (Liquid Antacid) | Batch 010122-BTN13Mfg Jan 2022 · Exp Dec 2023 | AssayAssay | CDTL ChennaiCDSCO lab | Aug 2022 |
| Ibuprofen Tablets I.P. 400 mg. | Batch 01019-BJA36Mfg Jan 2019 · Exp Dec 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2019 |
| Ibuprofen Tablets I.P. 400 mg | Batch 01019-BJA36Mfg Jan 2019 · Exp Dec 2020 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2019 |
| Ciprofloxacin Tablets IP 500 Mg | Batch 05028-BTN21Mfg Feb 2018 · Exp Jan 2020 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.